This PhD programme is run by a DFID consortium on disability research run by LSHTM. Zambart with UNZA…
STUDY DETAILS
- Category Current Studies
This a multi-country, epidemiologic study to assess the interferon gamma release assay (IGRA) positivity, and to build capacity to conduct a TB vaccine efficacy study, in populations with a high TB disease burden. The study is , sponsored by the Bill & Melinda Gates Medical Research Institute and study aims to recruit 8000 participants in about 14 countries.
The main objective of this study is to assess Interferon Gamma release assay (IGRA) positivity and to build capacity to conduct a Tuberculosis (TB) vaccine efficacy study in populations with high TB disease burden. The first stage of the study is not conducting any new interventions nor administering any investigational product.
The Zambart study site is found at Kanyama General Hospital with participants being recruited from the Kanyama community. Enrolment commenced on 07July2022 with 159 participants enrolled. We are currently following up these participants for a maximum period of 3 month with 6 monthly and yearly site visits with 2 monthly remote phone call contacts.
RELATED STUDIES
Tuberculosis (TB) in Zambia continues to be one of the major causes of morbidity and mortality…
This grant allows the team to continue analysing Pop ART data, around a set of key///
Intervention co-development to increase men’s HIV service use. The study aims to co-design, with men, healthcare…